A Single-arm, Prospective, Multi-center Study of Nucel in Patients Receiving Interbody Fusion for One and Two Level Degenerative Disease of the Lumbar Spine

Trial Profile

A Single-arm, Prospective, Multi-center Study of Nucel in Patients Receiving Interbody Fusion for One and Two Level Degenerative Disease of the Lumbar Spine

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 Aug 2017

At a glance

  • Drugs Amniotic cell therapy-NuCel (Primary)
  • Indications Intervertebral disc degeneration; Spinal disorders; Spondylolisthesis; Spondylosis
  • Focus Therapeutic Use
  • Sponsors Nutech Medical
  • Most Recent Events

    • 05 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top